ClinConnect ClinConnect Logo
Search / Trial NCT06402409

Exploring Multimorbidity in Patients With Spinal Pain

Launched by JACOB CHRISTIANSEN GANDLØSE · May 3, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Multimorbidity Comorbidities Comorbidity Neck Pain Back Pain Spinal Pain

ClinConnect Summary

This clinical trial, titled "Exploring Multimorbidity in Patients With Spinal Pain," is investigating how having multiple chronic health conditions—like back or neck pain—affects patients. Many people with spinal pain also deal with other health issues, and this study aims to understand how these conditions interact and impact patients’ treatment and overall health. The research will be conducted at two hospitals in Denmark, focusing on adults aged 18 and older who have been diagnosed with neck or back pain by a rheumatologist.

Participants in this study can expect to share their health experiences and may help researchers learn more about how doctors can better treat patients with spinal pain who also have other health concerns. To be eligible, individuals must be at least 18 years old, have a confirmed diagnosis of neck or back pain, and be able to communicate in Danish. It's important to note that participants will be actively helping to uncover valuable insights that could improve care for others facing similar challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years old or above
  • Are diagnosed with neck or back pain
  • Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
  • Speak, read and understand Danish
  • Exclusion Criteria:
  • Withdraw consent

About Jacob Christiansen Gandløse

Jacob Christiansen Gandløse is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, the organization collaborates with a network of healthcare professionals and research institutions to conduct high-quality clinical trials. Their expertise spans multiple therapeutic areas, ensuring a comprehensive approach to testing and development. Jacob Christiansen Gandløse prioritizes ethical standards and patient safety, striving to contribute valuable insights to the medical community and enhance treatment options for patients worldwide.

Locations

Aalborg, Region Nordjylland, Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported